Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.98)
# 3,885
Out of 5,033 analysts
327
Total ratings
26.83%
Success rate
-20.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNTI Senti Biosciences | Initiates: Buy | $12 | $2.15 | +458.14% | 1 | Oct 14, 2025 | |
| TGTX TG Therapeutics | Assumes: Buy | $60 | $34.67 | +73.06% | 1 | Oct 6, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $38 → $59 | $34.63 | +70.37% | 11 | Sep 30, 2025 | |
| IOBT IO Biotech | Downgrades: Neutral | n/a | $0.66 | - | 14 | Sep 29, 2025 | |
| AGEN Agenus | Reiterates: Buy | $23 | $3.88 | +492.78% | 20 | Sep 10, 2025 | |
| AGIO Agios Pharmaceuticals | Reiterates: Buy | $56 | $42.33 | +32.29% | 2 | Sep 4, 2025 | |
| BCTX BriaCell Therapeutics | Maintains: Buy | $32 → $40 | $11.85 | +237.55% | 15 | Aug 27, 2025 | |
| INKT MiNK Therapeutics | Upgrades: Buy | $35 | $14.03 | +149.47% | 14 | Aug 15, 2025 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $36 | $20.23 | +77.95% | 2 | Aug 13, 2025 | |
| FEMY Femasys | Maintains: Buy | $12 → $8 | $0.70 | +1,037.82% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.44 | +177.78% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $2.51 | +258.57% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $27 | $29.34 | -7.98% | 2 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $2.45 | +716.33% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $11.93 | +201.76% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $86.95 | +32.26% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $12 | $6.01 | +99.67% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.36 | +220.51% | 20 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.03 | +118.69% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $15.23 | +1,738.48% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.73 | +362.43% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $5.72 | +424.48% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.81 | +949.72% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.30 | +682.61% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $5.09 | +3,487.62% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.98 | +614.58% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.20 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $16.47 | +45.72% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.81 | +894.48% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.92 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $13.78 | +175.76% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.61 | +5,328.52% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.97 | - | 1 | Apr 25, 2024 |
Senti Biosciences
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $2.15
Upside: +458.14%
TG Therapeutics
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $34.67
Upside: +73.06%
AnaptysBio
Sep 30, 2025
Maintains: Buy
Price Target: $38 → $59
Current: $34.63
Upside: +70.37%
IO Biotech
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.66
Upside: -
Agenus
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.88
Upside: +492.78%
Agios Pharmaceuticals
Sep 4, 2025
Reiterates: Buy
Price Target: $56
Current: $42.33
Upside: +32.29%
BriaCell Therapeutics
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $11.85
Upside: +237.55%
MiNK Therapeutics
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $14.03
Upside: +149.47%
vTv Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $20.23
Upside: +77.95%
Femasys
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.70
Upside: +1,037.82%
Aug 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.44
Upside: +177.78%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $2.51
Upside: +258.57%
Jul 10, 2025
Maintains: Buy
Price Target: $6 → $27
Current: $29.34
Upside: -7.98%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $2.45
Upside: +716.33%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $11.93
Upside: +201.76%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $86.95
Upside: +32.26%
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $6.01
Upside: +99.67%
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $9.36
Upside: +220.51%
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.03
Upside: +118.69%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $15.23
Upside: +1,738.48%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.73
Upside: +362.43%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $5.72
Upside: +424.48%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.81
Upside: +949.72%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.30
Upside: +682.61%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $5.09
Upside: +3,487.62%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.98
Upside: +614.58%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $16.47
Upside: +45.72%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.81
Upside: +894.48%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.92
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $13.78
Upside: +175.76%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.61
Upside: +5,328.52%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.97
Upside: -